Sign in

CIK 0001782223

  • Emerging growth company

Pyxis Oncology, Inc.

Sign in to watch
Ticker
PYXS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831160910
Phone
+1 617-221-9059
Business address
321 HARRISON AVENUE, BOSTON, MA, 02118
Open-market buys, last 90 days
$0
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-24 FLAVIN JOHN L Director Grant or award · Stock Option (Right to Buy) +45,867 45,867
2025-03-31 FLAVIN JOHN L Director Grant or award · Stock Option (Right to Buy) +36,979 $0.98 $36K 36,979
2024-03-26 FLAVIN JOHN L Director Grant or award +35,219 413,015
2023-03-24 FLAVIN JOHN L Director Grant or award +139,355 377,796
2022-03-31 FLAVIN JOHN L Director Grant or award +66,831 238,441
2021-10-13 FLAVIN JOHN L Director Conversion +2,388 171,610
2021-10-13 FLAVIN JOHN L Director Conversion · Series B Convertible Preferred Stock −15,190 0
2021-10-07 FLAVIN JOHN L Director Grant or award · Stock Option (Right to buy) +42,191 42,191

Page 1 of 1 · 8 trades